Walgreens is mulling a bid to acquire AmerisourceBergen, the Chesterbrook-based pharmaceutical distributor, writes John George for the Philadelphia Business Journal.
A $400 billion, 10-year distribution deal first signed in 2013 made the two companies business partners. The agreement included stock options, which Walgreens has since exercised and now owns a 26 percent equity stake in AmerisourceBergen.
A spokeswoman for AmerisourceBergen, one of the region’s largest publicly traded companies that generated revenues of $153.1 billion in 2017, said the company’s corporate policy is “not to discuss any rumors or speculation regarding potential mergers or acquisitions.”
Walgreens is based in Deerfield, Ill.
Click here to read more about Walgreens’ interest in AmerisourceBergen in the Philadelphia Business Journal.